Jean-Pierre Bizzari, a veteran oncology drug developer, has joined the board of directors of ADC Therapeutics SA in Switzerland. The company has one approved ADC product and several in clinical development. Dr Bizzari has worked for more than 35 years in oncology drug development including as an executive of Celgene Corp, now part of Bristol Myers Squibb Co. He currently serves on the scientific advisory boards of France’s National Cancer Institute and the European Organisation for Research and Treatment of Cancer.
ADC Therapeutics announced the appointment on 1 July 2022.
Copyright 2022 Evernow Publishing Ltd
